HOME >> MEDICINE >> NEWS
UCI center finds perchlorate may be acceptable in drinking water at higher levels

Irvine, Calif., June 8, 2004 -- Even at significantly higher levels than recommended by the state's leading health assessment agency, the contaminant perchlorate in drinking water seems to pose no additional risks to healthy people, according to a recent report issued by the UC Irvine Urban Water Research Center.

The center reached this conclusion following a broad review of existing research on the rocket fuel manufacturing byproduct. Produced by an independent committee of scholars, the center's report is being provided to the California Department of Health Services and other policymakers as they wrestle with setting a statewide standard for perchlorate in drinking water.

The committee viewed the Office of Environmental Health Hazard Assessment's current public health goal of 6 parts per billion as well reasoned and in keeping with a value set only on health considerations. Its findings, however, show that exposure to perchlorate at levels below 100 parts per billion would still protect the public health.

Perchlorate a byproduct of rocket fuel manufacturing that was discharged as waste into groundwater supplies from defense sites is a chemical that interferes with the normal function of the thyroid gland. In adults and children, the thyroid helps regulate metabolism. In children, it also plays a major role in proper development. Impaired thyroid function in expectant mothers may affect the fetus and newborn. Treatment of rats with other chemicals that result in chronic lowering of thyroid hormones has been shown to produce thyroid gland tumors.

"Clearly more research should be conducted related to exposure to perchlorate, particularly with pregnant women and other susceptible individuals," said committee member Ronald Shank, a UCI professor and chair of community and environmental medicine. "But we found no evidence in the current studies that demonstrate a difference in health effects in healthy individuals between low leve
'"/>

Contact: Lori Brandt
lbrandt@uci.edu
949-824-5484
University of California - Irvine
8-Jun-2004


Page: 1 2 3

Related medicine news :

1. Advertising by academic medical centers may risk eroding public trust, says study
2. NJIT taps into solar energy to power new campus center
3. Multi-center study shows direct link between residential radon exposure and lung cancer
4. Leadership gift from Sulpizio Family for new state-of-the-art cardiovascular center at UCSD
5. Dedicated hospital stroke centers improve quality of acute care
6. Binghamton University launches microelectronics research center
7. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
8. Study investigates value of center of excellence designation
9. Multi-center study finds therapy boosts kidney transplants in highly sensitized patients
10. Federal funds given for regenerative medicine center
11. Team-centered program effective in reducing disordered eating among athletes

Post Your Comments:
(Date:5/18/2013)... (PRWEB) May 18, 2013 Adolescents, especially ... known as “Spice” or “K2” are landing in emergency ... to curb this drug epidemic with a new ... marijuana. , According to research from the National Institute ... popular illegal drug among American teenagers. In 2012, 11 ...
(Date:5/18/2013)... DF (PRWEB) May 18, 2013 The ... leading ayurvedic education institution in the West. Program is ... education. , Ayurveda is a healing modality practiced for ... ), it is considered that health begins when an ... profound understanding of their individual needs. Ayurveda aims to ...
(Date:5/18/2013)... Bay, CA (PRWEB) May 18, 2013 ... , has recently completed a stylish renovation that features ... advanced specialties. , From the ground up, this ... improved with fresh flooring, soothing colors and comfortable spa ... been installed, including an Apilus epilator machine. The ...
(Date:5/18/2013)... 2013 Losing weight remains to be the ... horde of new weight loss products available in the market ... studies about this newest weight loss supplement prove that dieting ... , Garcinia Cambogia is a sub-tropical fruit that is shaped ... fruit can suppress a person’s appetite, while it effectively burns ...
(Date:5/18/2013)... Spectrum Surgical Instruments will attend ... in Austin, TX where thousands of GI nursing ... opportunities. , Spectrum Surgical/STERIS will feature its ... capabilities and certified pre-owned equipment. Attendees will ... proper instrument care of flexible endoscopes. , ...
Breaking Medicine News(10 mins):Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2
(Date:5/17/2013)... Conn. , May 17, 2013 /PRNewswire-iReach/ -- ... and recombinant proteins, is placing renewed emphasis on ... the rise as a number of factors are ... for pharmaceutical makers and their delivery device partners ... previously refractory conditions, the growing trend toward self-administration ...
(Date:5/17/2013)... May 17, 2013  Boehringer Ingelheim will contribute ... at the American Thoracic Society International Conference (ATS ... May 17 – 22. Data will ... the treatment of chronic obstructive pulmonary disease (COPD) ... as investigational compounds for asthma, idiopathic pulmonary fibrosis ...
(Date:5/17/2013)... 2013  Sanofi (EURONEXT: SAN and NYSE: SNY ... JAKARTA , examining the selective JAK2 inhibitor SAR302503 ... dose groups. The primary endpoint assessed the proportion of ... data reported in previous trials, the most common adverse ... will be presented at an upcoming medical congress. ...
Breaking Medicine Technology:Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
Cached News: